Mary K Dahmer1, Guangyu Yang2, Min Zhang2, Michael W Quasney3, Anil Sapru4, Heidi M Weeks5, Pratik Sinha6, Martha A Q Curley7, Kevin L Delucchi8, Carolyn S Calfee9, Heidi Flori3. 1. Department of Pediatrics, Division of Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: mkdahmer@umich.edu. 2. Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA. 3. Department of Pediatrics, Division of Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA. 4. Department of Pediatrics, University of California, Los Angeles, Los Angeles, CA, USA. 5. Department of Nutritional Sciences, University of Michigan, Ann Arbor, MI, USA. 6. Department of Anesthesia, Washington University, St Louis, MO, USA. 7. Department of Family and Community Health (School of Nursing), Division of Anesthesia and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Research Institute, Children's Hospital of Philadelphia, Philadelphia, PA. 8. Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, San Francisco, CA, USA. 9. Department of Medicine, Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, University of California, San Francisco, San Francisco, CA, USA.
Abstract
BACKGROUND: Previous latent class analysis of adults with acute respiratory distress syndrome (ARDS) identified two phenotypes, distinguished by the degree of inflammation. We aimed to identify phenotypes in children with ARDS in whom developmental differences might be important, using a latent class analysis approach similar to that used in adults. METHODS: This study was a secondary analysis of data aggregated from the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial and the Genetic Variation and Biomarkers in Children with Acute Lung Injury (BALI) ancillary study. We used latent class analysis, which included demographic, clinical, and plasma biomarker variables, to identify paediatric ARDS (PARDS) phenotypes within a cohort of children included in the RESTORE and BALI studies. The association of phenotypes with clinically relevant outcomes and the performance of paediatric data in adult ARDS classification algorithms were also assessed. FINDINGS: 304 children with PARDS were included in this secondary analysis. Using latent class analysis, a two-class model was a better fit for the cohort than a one-class model (p<0·001). Latent class analysis identified two classes: class 1 (181 [60%] of 304 patients with PARDS) and class 2 (123 [40%] of 304 patients with PARDS), referred to as phenotype 1 and 2 hereafter. Phenotype 2 was characterised by higher concentrations of inflammatory biomarkers, a higher incidence of vasopressor use, and more frequent diagnosis of sepsis, consistent with the adult hyperinflammatory phenotype. All levels of severity of PARDS were observed across both phenotypes. Children with the hyperinflammatory phenotype (phenotype 2) had worse clinical outcomes than those with the hypoinflammatory phenotype (phenotype 1), with a longer duration of mechanical ventilation (median 10·0 days [IQR 6·3-21·0] for phenotype 2 vs 6·6 days [4·1-10·8] for phenotype 1, p<0·0001), and higher incidence of mortality (17 [13·8%] of 123 patients vs four [2·2%] of 181 patients, p=0·0001). When using adult phenotype classification algorithms in children, the soluble tumour necrosis factor receptor-1 (sTNFr1), vasopressor use, and interleukin (IL)-6 variables gave an area under the curve (AUC) of 0·956, and the sTNFr1, vasopressor use, and IL-8 variables gave an AUC of 0·954, compared with the gold standard of latent class analysis. INTERPRETATION: Latent class analysis identified two phenotypes in children with ARDS with characteristics similar to those in adults, including worse outcomes among patients with the hyperinflammatory phenotype. PARDS phenotypes should be considered in design and analysis of future clinical trials in children. FUNDING: US National Institutes of Health.
BACKGROUND: Previous latent class analysis of adults with acute respiratory distress syndrome (ARDS) identified two phenotypes, distinguished by the degree of inflammation. We aimed to identify phenotypes in children with ARDS in whom developmental differences might be important, using a latent class analysis approach similar to that used in adults. METHODS: This study was a secondary analysis of data aggregated from the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial and the Genetic Variation and Biomarkers in Children with Acute Lung Injury (BALI) ancillary study. We used latent class analysis, which included demographic, clinical, and plasma biomarker variables, to identify paediatric ARDS (PARDS) phenotypes within a cohort of children included in the RESTORE and BALI studies. The association of phenotypes with clinically relevant outcomes and the performance of paediatric data in adult ARDS classification algorithms were also assessed. FINDINGS: 304 children with PARDS were included in this secondary analysis. Using latent class analysis, a two-class model was a better fit for the cohort than a one-class model (p<0·001). Latent class analysis identified two classes: class 1 (181 [60%] of 304 patients with PARDS) and class 2 (123 [40%] of 304 patients with PARDS), referred to as phenotype 1 and 2 hereafter. Phenotype 2 was characterised by higher concentrations of inflammatory biomarkers, a higher incidence of vasopressor use, and more frequent diagnosis of sepsis, consistent with the adult hyperinflammatory phenotype. All levels of severity of PARDS were observed across both phenotypes. Children with the hyperinflammatory phenotype (phenotype 2) had worse clinical outcomes than those with the hypoinflammatory phenotype (phenotype 1), with a longer duration of mechanical ventilation (median 10·0 days [IQR 6·3-21·0] for phenotype 2 vs 6·6 days [4·1-10·8] for phenotype 1, p<0·0001), and higher incidence of mortality (17 [13·8%] of 123 patients vs four [2·2%] of 181 patients, p=0·0001). When using adult phenotype classification algorithms in children, the soluble tumour necrosis factor receptor-1 (sTNFr1), vasopressor use, and interleukin (IL)-6 variables gave an area under the curve (AUC) of 0·956, and the sTNFr1, vasopressor use, and IL-8 variables gave an AUC of 0·954, compared with the gold standard of latent class analysis. INTERPRETATION: Latent class analysis identified two phenotypes in children with ARDS with characteristics similar to those in adults, including worse outcomes among patients with the hyperinflammatory phenotype. PARDS phenotypes should be considered in design and analysis of future clinical trials in children. FUNDING: US National Institutes of Health.
Authors: Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2015-11-01 Impact factor: 21.405
Authors: Katie R Famous; Kevin Delucchi; Lorraine B Ware; Kirsten N Kangelaris; Kathleen D Liu; B Taylor Thompson; Carolyn S Calfee Journal: Am J Respir Crit Care Med Date: 2017-02-01 Impact factor: 21.405
Authors: Nienke J Vet; Janneke M Brussee; Matthijs de Hoog; Miriam G Mooij; Carin W M Verlaat; Isabel S Jerchel; Ron H N van Schaik; Birgit C P Koch; Dick Tibboel; Catherijne A J Knibbe; Saskia N de Wildt Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405
Authors: Robinder G Khemani; Lincoln Smith; Yolanda M Lopez-Fernandez; Jeni Kwok; Rica Morzov; Margaret J Klein; Nadir Yehya; Douglas Willson; Martin C J Kneyber; Jon Lillie; Analia Fernandez; Christopher J L Newth; Philippe Jouvet; Neal J Thomas Journal: Lancet Respir Med Date: 2018-10-22 Impact factor: 30.700
Authors: Hector R Wong; James G Williams; Rashika Joshi; David Haslam; Nadir Yehya; Rhonda L Jones; Aditi Paranjpe; Mario Pujato; Krishna M Roskin; Patrick M Lahni; Brian M Varisco Journal: Respir Res Date: 2022-07-09
Authors: Ericka L Fink; Patrick M Kochanek; Ashok Panigrahy; Sue R Beers; Rachel P Berger; Hülya Bayir; Jose Pineda; Christopher Newth; Alexis A Topjian; Craig A Press; Aline B Maddux; Frederick Willyerd; Elizabeth A Hunt; Ashley Siems; Melissa G Chung; Lincoln Smith; Jesse Wenger; Lesley Doughty; J Wesley Diddle; Jason Patregnani; Juan Piantino; Karen Hallermeier Walson; Binod Balakrishnan; Michael T Meyer; Stuart Friess; David Maloney; Pamela Rubin; Tamara L Haller; Amery Treble-Barna; Chunyan Wang; Robert R S B Clark; Anthony Fabio Journal: JAMA Netw Open Date: 2022-09-01